In Depth
Also in this section
Inborn errors of metabolism elicit unique challenges for therapy development
GLP-1RAs and opioid use disorder: a new frontier in addiction treatment
European agencies catch up with speedier regulatory pathways for CGTs in the US
USAID funding fallout: sponsors, and agencies may have to fill funding gap
Pfizer’s bet on gene therapies in haemophilia has been a bust